Literature DB >> 3843592

Recent trends in cardiac sarcoidosis research in Japan.

M Sekiguchi, M Kaneko, M Hiroe, K Hirosawa.   

Abstract

Our recent survey of the Japanese literature, actual case experience, and previous studies revealed the following results. Fifty-three cases were reported in which the main cause of death in sarcoidosis was congestive heart failure (11 of 17 cases, 64.7%) and not sudden death as was previously believed. ECG analysis revealed that third degree AV block, bundle branch block, and ventricular arrhythmias were the most frequent findings indicating the presence of cardiac sarcoidosis. It was recognized that in the Japanese population fatal myocardial sarcoidosis or clinical diagnosed cardiac sarcoidosis occurred most frequently in females over the age of 40 years. It is suggested that myocardial changes progress independently of granulomatous changes. This is due to the detection of a high incidence of basal lamina layering of myocardial capillaries (14 of 18 cases, 77.8%) and is considered to play a significant role in the progression of this disease. Radionuclide studies showed that thallium scintigraphy or technetium ventriculography were positive in those cases where ECG abnormalities are prominent, indicating the presence of myocardial disease. Previous therapeutic studies of cardiac sarcoidosis have shown a decrease in the incidence of sudden death; death due to congestive heart failure occurred more frequently despite pacemaker implantation. Control of congestive heart failure is thus regarded as the most important aspect of improved treatment and prognosis.

Entities:  

Mesh:

Year:  1985        PMID: 3843592     DOI: 10.1007/bf02072359

Source DB:  PubMed          Journal:  Heart Vessels Suppl        ISSN: 0935-736X


  7 in total

Review 1.  Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11).

Authors:  W C Roberts; H A McAllister; V J Ferrans
Journal:  Am J Med       Date:  1977-07       Impact factor: 4.965

Review 2.  Basal lamina layering in diabetes mellitus. Evidence for accelerated rate of cell death and cell regeneration.

Authors:  R Vracko
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

3.  Sarcoid heart disease: a review and an appeal.

Authors:  H A Fleming
Journal:  Thorax       Date:  1980-09       Impact factor: 9.139

4.  Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis.

Authors:  M Sekiguchi; Y Numao; M Imai; T Furuie; R Mikami
Journal:  Jpn Circ J       Date:  1980-04

5.  Thallium-scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction. An analysis of 44 patients.

Authors:  E L Kinney; G L Jackson; W C Reeves; R Zelis
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

6.  Clinicopathological study of fatal myocardial sarcoidosis.

Authors:  Y Matsui; K Iwai; T Tachibana; T Fruie; N Shigematsu; T Izumi; A H Homma; R Mikami; O Hongo; Y Hiraga; M Yamamoto
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

7.  Ultrastructural features of the endomyocardium in patients with eosinophilic heart disease. An endomyocardial biopsy study.

Authors:  M Sekiguchi; Z X Yu; M Take; M Hiroe; K Hirosawa; T Shirai; T Ishide; T Takahashi
Journal:  Jpn Circ J       Date:  1984-12
  7 in total
  2 in total

Review 1.  Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations.

Authors:  M Sekiguchi; Y Yazaki; M Isobe; M Hiroe
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

2.  Assessment of cardiac involvement in sarcoidosis by echocardiography.

Authors:  Marta Focardi; Andrea Picchi; Nikolas Nikiforakis; Elena Bargagli; Antonella Fossi; Claudia Maggiorelli; Sergio Mondillo; Paola Rottoli
Journal:  Rheumatol Int       Date:  2009-05-16       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.